Therefore, The BRD4 protein serves as a pivotal transcriptional regulator and is implicated in the control of gene expression for several super-enhancer-associated genes, such as the prominent oncogene c-MYC.6 This suggests that the manipulation of BET family proteins might have significant potential as a viable strategy for cancer treatment. The gene discussed is MYC; the disease is cancer.